x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001239
| Product Information | |
|---|---|
| Product Name | Human Leptin Receptor ELISA Kit |
| Species | Human |
| Description | Human Leptin Receptor ELISA kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of Human Leptin Receptor protein in human serum, plasma, cell culture supernatant, and cell and tissue extract samples. It uses our proprietary ELISA technology. Quantitate Human Leptin Receptor with 20.4 pg/mL sensitivity ELISA technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our ELISA plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. |
| Sample Types | Serum, Cell Lysate, Cell Culture Media, Hep Plasma, Edta Plasma |
| Detection Range | 93.75 pg/mL - 6000 pg/mL |
| Sensitivity | 20.4 pg/mL |
| Target Information | |
|---|---|
| Target Name | LEPR |
| UniProt No. | P48357 |
| Gene ID | 3953 |
| Target Description | Receptor for obesity factor. On ligand binding, mediates signaling through JAK2/STAT3. Involved in the regulation of fat metabolism and, in a hematopoietic pathway, required for normal lymphopoiesis. May play a role in reproduction. Can also mediate the ERK/FOS signaling pathway. |
| Alternative Names | CD 295; CD295; CD295 antigen; Db; Fa; HuB219; LEP R; LEP-R; LEPR; LEPR_HUMAN; LEPRD; Leptin receptor; Leptin receptor fatty; Leptin receptor gene related protein; Leptin receptor precursor; OB R gene related protein; OB receptor; OB-R; OB-RGRP; obl; Obr |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at +4°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
